同源康醫藥-B

02410
3.1750.78% ( -0.025 )
延遲 已收盤: 11月19日 16:08:07

股東

全部股東

股東類型

  • 公眾及其他35.75%
  • 機構投資者26.94%
  • 私人企業25.94%
  • 僱員持股計劃6.16%
  • 其他5.21%

主要股東

主要股東 最新
股東
Tetranov Pharmaceutical (Zhengzhou) Co., Ltd.
25.94%9,978.75 萬0.00%+016/09/2026
TYK Medicines, Inc,ESOP
6.16%2,367.85 萬0.00%+016/09/2026
Changxing Xingchang Industrial Investment Partnership (Limited Partnership)
4.42%1,700.00 萬0.00%+018/02/2025
Jiangsu Addor Equity Investment Fund Management Co., Ltd.
4.02%1,545.45 萬0.00%+022/08/2025
Ningbo Meishan Bonded Port Area Houji Tongnuo Investment Management Partnership (Limited Partnership
3.68%1,414.66 萬0.00%+0
Sichuan Huiyu Pharmaceutical Co., Ltd.
2.72%1,046.86 萬0.00%+027/03/2025
Jiangsu Addor Capital Results Innovation Venture Capital Fund (Limited Partnership)
2.50%960.00 萬0.00%+018/02/2025
Franklin Templeton Sealand Fund Management Co., Ltd.
2.38%913.92 萬0.00%+031/12/2025
China Universal Asset Management Company Ltd.
2.24%861.12 萬0.00%+031/12/2025
Hong GuNon-Executive Director
2.08%801.00 萬0.00%+0
Barclays Bank Plc
1.67%640.55 萬0.00%+018/09/2025
Ningbo Meishan Bonded Port Area Houyang Tongchi Investment Management Partnership (Limited Partnersh
1.37%525.80 萬0.00%+0
Zhuzhou CRRC Times Investment Co., Ltd.
1.20%460.80 萬0.00%+018/02/2025
Nanjing Addor Equity Investment Management Enterprise (Limited Partnership)
0.86%330.00 萬0.00%+022/08/2025
Yinhua Fund Management Co., Ltd.
0.81%311.50 萬0.00%+031/12/2025
ICBC UBS Asset Management (International) Company Limited
0.50%191.05 萬0.00%+031/12/2025
E Fund Management Co., Ltd.
0.43%164.40 萬0.00%+031/12/2025
Yusheng WuFounder, Executive Chairman & CEO
0.41%157.50 萬--+157.50 萬16/09/2026
Bosera Asset Management Co., Ltd.
0.33%127.95 萬0.00%+031/12/2025
Fullgoal Fund Management Co. Ltd.
0.21%80.75 萬0.00%+031/12/2025